University of Bristol

This Week in PNAS

In PNAS this week: DNA vaccine-based approach for Duchenne muscular dystrophy tested in mice, antimicrobial found in bear saliva, and more.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

Mishandling Them

The Guardian reports that labs in the UK have had safety incidents involving pathogens.

Living DNA can break down the origins of a customer’s ancestry into 21 distinct regions within Britain alone, as well as across 80 different worldwide populations.

University of Bristol researchers examine the Phormidesmis priestleyi BC1401 genome, a bacterium from the Greenland Ice Sheet.

In Genome Biology this week: computational approach to tease apart clonal tumor lineages, cell type-specific lncRNA expression in developing human neocortex, and more.

Expanding on past genome-wide association data, two teams delved into functional and phenotypic studies related to known schizophrenia-associated variants.

Ten new atopic dermatitis risk loci turned up in a genome-wide association study meta-analysis involving hundreds of thousands of individuals.

NEW YORK (GenomeWeb News) – Affymetrix and the UK's University of Bristol have partnered to develop a wheat genotyping array to be used in efforts to study wheat genetics and in breeding programs, Affymetrix said today.

NEW YORK (GenomeWeb News) - In Lancet Respiratory Medicine, an international team led by investigators at the Duke University Medical Center described findings from a prospective study looking at asthma-related information that can be

Pages

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.